The clinical profile and associated mortality in people with and without diabetes with Coronavirus disease 2019 on admission to acute hospital services
- PMID: 34859617
- PMCID: PMC8754243
- DOI: 10.1002/edm2.309
The clinical profile and associated mortality in people with and without diabetes with Coronavirus disease 2019 on admission to acute hospital services
Abstract
Introduction: To assess if in adults with COVID-19, whether those with diabetes and complications (DM+C) present with a more severe clinical profile and if that relates to increased mortality, compared to those with diabetes with no complications (DM-NC) and those without diabetes.
Methods: Service-level data was used from 996 adults with laboratory confirmed COVID-19 who presented to the Queen Elizabeth Hospital Birmingham, UK, from March to June 2020. All individuals were categorized into DM+C, DM-NC, and non-diabetes groups. Physiological and laboratory measurements in the first 5 days after admission were collated and compared among groups. Cox proportional hazards regression models were used to evaluate associations between diabetes status and the risk of mortality.
Results: Among the 996 individuals, 104 (10.4%) were DM+C, 295 (29.6%) DM-NC and 597 (59.9%) non-diabetes. There were 309 (31.0%) in-hospital deaths documented, 40 (4.0% of total cohort) were DM+C, 99 (9.9%) DM-NC and 170 (17.0%) non-diabetes. Individuals with DM+C were more likely to present with high anion gap/metabolic acidosis, features of renal impairment, and low albumin/lymphocyte count than those with DM-NC or those without diabetes. There was no significant difference in mortality rates among the groups: compared to individuals without diabetes, the adjusted HRs were 1.39 (95% CI 0.95-2.03, p = 0.093) and 1.18 (95% CI 0.90-1.54, p = 0.226) in DM+C and DM-C, respectively.
Conclusions: Those with COVID-19 and DM+C presented with a more severe clinical and biochemical profile, but this did not associate with increased mortality in this study.
Keywords: COVID-19; complications; diabetes.
© 2021 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd.
Conflict of interest statement
SAM has received research support from Novo Nordisk Research Foundation UK and Academy of medical Sciences. SB has received grants, personal fees, and support to attend educational meetings from Novo Nordisk; grants from The Binding Site; personal fees from AstraZeneca, Merck, Sharpe & Dohme, and Janssen; personal fees and support to attend educational meetings from Boehringer Ingelheim; personal fees and support to attend educational meetings from Eli Lilly; and personal fees and support to attend educational meetings from Sanofi‐Aventis and NAPP. WH has received Received Research Grants, Travel Grant and Consultancy for following AZ, BI, Eli Lilly, Jansen, Novo Nordisk, Sanofi, NAPP and MSD. Other authors have no declarations.
Figures


Similar articles
-
The outcomes of patients with diabetes mellitus in The Philippine CORONA Study.Sci Rep. 2021 Dec 24;11(1):24436. doi: 10.1038/s41598-021-03898-1. Sci Rep. 2021. PMID: 34952903 Free PMC article.
-
The effect of diabetes mellitus on COVID-19 mortality among patients in a tertiary-level hospital in Bandung, Indonesia.PLoS One. 2023 Jun 15;18(6):e0286797. doi: 10.1371/journal.pone.0286797. eCollection 2023. PLoS One. 2023. PMID: 37319126 Free PMC article.
-
The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea.Diabetes Metab J. 2020 Aug;44(4):602-613. doi: 10.4093/dmj.2020.0146. Epub 2020 Aug 12. Diabetes Metab J. 2020. PMID: 32794386 Free PMC article.
-
Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis.Acta Diabetol. 2021 Aug;58(8):1101-1110. doi: 10.1007/s00592-021-01701-1. Epub 2021 Mar 20. Acta Diabetol. 2021. PMID: 33778910 Free PMC article.
-
Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis.Arch Med Res. 2020 Oct;51(7):700-709. doi: 10.1016/j.arcmed.2020.07.005. Epub 2020 Aug 7. Arch Med Res. 2020. PMID: 32811670 Free PMC article.
Cited by
-
Diabetes medication recommendation system using patient similarity analytics.Sci Rep. 2022 Dec 3;12(1):20910. doi: 10.1038/s41598-022-24494-x. Sci Rep. 2022. PMID: 36463296 Free PMC article.
References
-
- Chen Y, Gong X, Wang L, Guo J. “Effects of hypertension, diabetes and coronary heart disease on COVID‐19 diseases severity: a systematic review and meta‐analysis,” medRxiv, p. 2020.03.25.20043133, Mar. 2020.
-
- 2011 Census: Key Statistics for Local Authorities in England and Wales. ONS.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous